STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #138 by analyst upside · 2026-06-27
PAVM
PAVmed Inc.
Healthcare · Market Cap $36M · P/E 0x
ANALYST PRICE TARGET
+612.9%
implied upside to consensus target
Current Price $5.05
Consensus Target $36.0
Bull Target $56.0
Bear Target $16.0
Analysts Covering 2
ANALYST CONSENSUS — STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $3.85
52-Week High $28.44
YTD Return -31.1%
FUNDAMENTALS
Market Cap $36M
P/E Ratio (TTM) N/A
Forward P/E -2.1x
EPS (TTM) $-48.31
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $3.85
52-Week High $28.44
Current Price $5.05
Bear Target $16.0
Bull Target $56.0
● Now $5.05 ● Target $36.0
TRADING DATA
Avg Volume 17K
YTD Return -31.1%
Analyst Count 2
Consensus Strong Buy
Upside to Target +612.9%
Last Updated 2026-06-27

ANALYST SUMMARY

PAVmed Inc. (PAVM) is currently trading at $5.05 with a Wall Street consensus price target of $36.0, implying potential upside of 612.9% over the next 12 months. 2 analysts currently cover PAVM, with a consensus rating of Strong Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $56.0, while the most cautious has a target of $16.0.

PAVM operates in the Healthcare sector with a market capitalisation of $36M. The stock is down 31.1% year-to-date and is currently trading near the lower end of its 52-week range of $3.85 – $28.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PAVM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital — Reiterated
Buy → Buy 2026-06-08 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2026-04-09 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-12-10 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-10-06 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-06-06 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-04-21 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2024-12-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →